Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 60

Results For "ISA"

1072 News Found

SPARSH Hospital organises a walkathon to create awareness on organ donation
Hospitals | August 15, 2022

SPARSH Hospital organises a walkathon to create awareness on organ donation

Donor privilege cards given to the families of all the donors from across Karnataka as a token of appreciation


MoU signed between Ministry of Ayush and MeitY
Policy | August 13, 2022

MoU signed between Ministry of Ayush and MeitY

MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years


Roche gets USFDA approval of Xofluza to treat influenza in children
Drug Approval | August 13, 2022

Roche gets USFDA approval of Xofluza to treat influenza in children

Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age


GL Chemtech partners with Edgewater Capital to accelerate growth
News | August 12, 2022

GL Chemtech partners with Edgewater Capital to accelerate growth

Investment in response to increased demand for North American-based chemistry services


Apollo Hospitals posts Q1 FY23 consolidated PAT at Rs. 317.11 Cr
News | August 12, 2022

Apollo Hospitals posts Q1 FY23 consolidated PAT at Rs. 317.11 Cr

Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.


Agriculture Minister Narendra Singh Tomar launches indigenous vaccine for Lumpy Skin disease
Policy | August 11, 2022

Agriculture Minister Narendra Singh Tomar launches indigenous vaccine for Lumpy Skin disease

The vaccine has been developed by the National Equine Research Center, Hisar (Haryana) in collaboration with the Indian Veterinary Research Institute, Izzatnagar (Bareilly)


JB Pharma records revenue growth of 30% in Q1 FY23
News | August 09, 2022

JB Pharma records revenue growth of 30% in Q1 FY23

Profit after Tax stood at Rs. 105 crore as compared to Rs. 119 crore on account of higher treasury income in Q1 FY22, non-cash ESOP cost, depreciation on account of acquired brands and finance costs in Q1 FY23


Rossari Biotech Q1 FY23 revenue up 88%; Profit up 17%
News | August 08, 2022

Rossari Biotech Q1 FY23 revenue up 88%; Profit up 17%

Profit after Tax (PAT) was up 18% for Q1 FY23 to reach Rs. 28.7 crore whereas EBITDA was up 52% to reach Rs. 57.7 crore


Shivalik Rasayan Ltd inks marketing agreement with China Chinopharma
News | August 03, 2022

Shivalik Rasayan Ltd inks marketing agreement with China Chinopharma

The CSC shall hold Market Authorisation (MA) to sell SRL's BUSALFAN, API exclusively in China territory.


Ensure time-bound Infrastructure development of Ayush National Institutes/Central Councils projects: Sonowal
Policy | August 03, 2022

Ensure time-bound Infrastructure development of Ayush National Institutes/Central Councils projects: Sonowal

Ministry of Ayush has fast tracked up-gradation and construction of various Ayush Infrastructure across the country